This is the authors' abstract. We don't add key points for this paper.
Nucleocytoplasmic transport occurs via nuclear pore complexes (NPCs), ~40-60 nm wide pores lined with intrinsically disordered proteins that are rich in Phe-Gly motifs (FG-Nups) that form a selective barrier. Molecules larger than ~50 kDa are increasingly blocked for transport unless they are bound to a nuclear transport receptor such as the karyopherin (Kap) family of proteins. How the amino acid sequence of FG-Nups contributes to this selectivity is not fully understood. Here, we present de novo designed artificial FG-Nups with a systematically varied FG-repeat spacing and charge-to-hydrophobicity ratio (C/H). Starting from a reference sequence termed NupY (with the average properties of yeast GLFG-Nups), we design, synthesize, and experimentally test a library of NupY variants using quartz crystal microbalance with dissipation monitoring and phase separation assays. We find that the spacing between FG-motifs governs Kap95 absorption into the FG-Nup phase, while increasing C/H results in higher avidity for Kap95 due to an increased accessibility of FG-motifs. Molecular dynamics simulations of transport through NupY-coated pores show a reduced barrier function for noncohesive variants and the highest transport selectivity for designs close to native GLFG-Nups. We postulate that a balance between steric hindrance and enthalpic gain from multivalent Kap-FG-Nup interactions drives the spatial and temporal partitioning of Kaps in the NPC.
No takes yet. Share an insight, caveat, or question.
Vries et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: